Which hospital in Shanghai has Fruquintinib?

Fruquintinib (Fruquintinib) is a VEGF receptor inhibitor used to treat metastatic colorectal cancer. Fruquintinib is a new targeted anti-cancer drug with complete intellectual property rights independently developed by a local Chinese company. It could offer hope to patients with metastatic colorectal cancer who have experienced disease progression despite having received at least two chemotherapy regimens. In clinical studies, fruquintinib has been shown to significantly extend patient survival. Fruquintinib is already available in China, so patients can purchase the drug from majorlocal legal pharmacies or hospital pharmacies with a doctor’s prescription. If patients want to purchase fruquintinib, which is more cost-effective, please consult a medical consultant.